Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-24 @ 3:04 PM
NCT ID:
NCT04482959
Eligibility Criteria:
Inclusion Criteria:
* Symptomatic women aged 18-45 years diagnosed by transvaginal sonography (TVS) to have single type 0 or I submucous uterine myomas according to FIGO classification system with a largest diameter ≤ 4 cm and myometrial free margin of at least 10 mm.
Exclusion Criteria:
* • Age \< 18 or \> 45 years.
* Uterine septum or structural uterine abnormality (including multiple uterine fibroids and/or multiple submucous myomas)
* Present or history of cervical or uterine malignancies.
* Active pelvic infection.
* Chronic medical diseases (cardiopulmonary, thromboembolic, hepatic, or renal diseases).
* Bleeding disorders.
* Patients receiving anticoagulant therapy.
* Patients receiving gonadotropin-releasing hormone (GnRH) analogues.
* History of adverse reaction contraindications for Carbetocin.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT04482959
Study Brief:
Protocol Section:
NCT04482959